Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing innovative treatments for rare and ultra-rare genetic conditions. Its operations span North America, Europe, and other international markets. The company's portfolio of marketed biologic products addresses several serious diseases. This includes Crysvita (burosumab), an antibody that targets fibroblast growth factor 23, used to treat X-linked hypophosphatemia and tumor-induced osteomalacia. Mepsevii offers enzyme replacement therapy for both pediatric and adult patients suffering from Mucopolysaccharidosis VII. Dojolvi is available for individuals with long-chain fatty acid oxidation disorders, while Evkeeza (evinacumab) provides a treatment option for homozygous familial hypercholesterolemia. Ultragenyx also boasts a robust pipeline of investigational therapies. Notable candidates include DTX401, an adeno-associated virus 8 (AAV8) gene therapy for glycogen storage disease type Ia, and DTX301, another AAV8 gene therapy aimed at ornithine transcarbamylase deficiency. Other promising developments feature UX143, a human monoclonal antibody for osteogenesis imperfecta; GTX-102, an antisense oligonucleotide designed for Angelman syndrome; UX701, targeting Wilson disease; and UX053, in development for glycogen storage disease type III. To advance its research and development efforts, Ultragenyx Pharmaceutical Inc. maintains strategic collaboration and licensing agreements with numerous partners, such as Kyowa Kirin Co., Ltd., Saint Louis University, REGENXBIO Inc., Bayer Healthcare LLC, GeneTx, Mereo, University of Pennsylvania, Arcturus Therapeutics Holdings Inc., Solid Biosciences Inc., and Daiichi Sankyo Co., Ltd. The company was founded in 2010 and operates from its headquarters in Novato, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Ultragenyx Pharmaceutical Inc.
NASDAQ:RAREHealthcare · Biotechnology
-4.05%$16.10
AH$16.10+0.00%vs close
Mkt Cap$1.59B
Float93.53M
O/S98.59M
Vol
$ Vol
RVOL
Inst Own-
SI21.5%
Earnings
Dilution
Financials Summary
Revenue$673M
Net Income-$575M
Total Assets$1.53B
Free Cash Flow-$472M
Debt & Equity
Debt 107%
Total Debt$1.28B
Total Equity-$80M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in RARE's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$1.53B
Liabilities$1.6B
Accounts Receivable$159M
Accounts Payable$31M
Inventory$52M
PP&E (Net)$267M
Goodwill$44M
Intangible Assets$176M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $673M | $560.23M | $434.25M | $363.33M | $351.41M | $271.03M | $103.71M | $51.49M | $2.61M | $133K | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | 20.1% | 29.0% | 19.5% | 3.4% | 29.7% | 161.3% | 101.4% | 1871.5% | 1863.9% | - | - | - | - | - | - |
| Cost of Revenue | $109M | $76.73M | $45.21M | $28.32M | $16.01M | $6.13M | $9.01M | $1.15M | $1K | $183.2M | $1.38M | $0 | $0 | $0 | $0 |
| Gross Profit | $564M | $483.5M | $389.04M | $335.01M | $335.4M | $264.9M | $94.71M | $50.35M | $2.61M | -$183.07M | -$1.38M | $0 | $0 | $0 | $0 |
| Gross Margin | 83.8% | 86.3% | 89.6% | 92.2% | 95.4% | 97.7% | 91.3% | 97.8% | 100.0% | -137647.4% | - | - | - | - | - |
| Research and Development | $750M | $697.87M | $648.45M | $705.79M | $497.15M | $412.08M | $357.36M | $294M | $231.64M | $183.2M | $114.74M | $45.97M | $27.83M | $12.64M | $4.72M |
| Selling, General, and Administrative | $349M | $321.61M | $309.8M | $278.14M | $219.98M | $182.93M | $161.52M | $127.72M | $99.91M | $64.94M | $33M | $10.81M | $4.45M | $3.34M | $1.84M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.95M | $0 | $2.17M | -$200K | $0 | $0 | $0 | -$22K |
| Total Operating Expenses | $1.1B | $1.02B | $958.25M | $983.93M | $717.13M | $595.02M | $518.88M | $421.72M | $331.55M | $248.14M | $147.74M | $56.78M | $32.28M | $15.98M | $6.56M |
| Operating Income (EBIT) | -$535M | -$535.97M | -$569.21M | -$648.92M | -$381.74M | -$330.12M | -$424.17M | -$371.37M | -$328.94M | -$248.01M | -$147.74M | -$56.78M | -$32.28M | -$15.98M | -$6.56M |
| Operating Margin | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% | -121.8% | -409.0% | -721.2% | -12593.5% | -186471.4% | - | - | - | - | - |
| Interest Expense | $62M | $63.04M | $66M | $43.02M | $29.42M | $33.29M | $1.14M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $270K |
| Interest Income | $25M | $36.51M | $26.69M | $11.07M | $1.93M | $7.04M | $13.24M | $9.54M | $4.07M | $3.79M | $2.32M | $608K | $216K | $1K | $4K |
| Other Income (Expense) | -$36M | -$31.61M | -$39.26M | -$52.81M | -$71.24M | $144.76M | $24.73M | $174.28M | $10.6M | $2.17M | $2.12M | -$3.02M | -$2.79M | -$349K | -$288K |
| Income Before Tax (EBT) | -$571M | -$567.59M | -$608.46M | -$701.73M | -$452.98M | -$185.36M | -$399.44M | -$197.1M | -$318.34M | -$245.84M | -$145.62M | -$59.8M | -$35.07M | -$16.33M | -$6.85M |
| Income Tax Expense | $4M | $1.6M | -$1.82M | $5.7M | $1.04M | $1.21M | $3.28M | $514K | -$16.2M | $35K | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$575M | -$569.18M | -$606.64M | -$707.42M | -$454.02M | -$186.57M | -$402.73M | -$197.61M | -$302.14M | -$245.87M | -$145.62M | -$59.8M | -$35.07M | -$16.33M | -$6.85M |
| Net Income Margin | -85.4% | -101.6% | -139.7% | -194.7% | -129.2% | -68.8% | -388.3% | -383.7% | -11567.3% | -184867.7% | - | - | - | - | - |
| Supplementary Data | |||||||||||||||
| EPS | -5.83 | -6.29 | -8.25 | -10.12 | -6.70 | -3.07 | -7.12 | -3.97 | -7.12 | -6.21 | -3.96 | -2.08 | -1.21 | -0.71 | -0.30 |
| Diluted EPS | -5.83 | -6.29 | -8.25 | -10.12 | -6.70 | -3.07 | -7.12 | -3.97 | -7.12 | -6.21 | -3.96 | -2.08 | -1.21 | -0.71 | -0.30 |
| Weighted Average OS | 98.60M | 90.54M | 73.54M | 69.91M | 67.80M | 60.85M | 56.58M | 49.78M | 42.45M | 39.59M | 36.78M | 28.76M | 29.06M | 23.06M | 23.06M |
| EBITDA | -$474M | -$469M | -$516.45M | -$640.49M | -$410.32M | -$139.81M | -$389.77M | -$177.56M | -$312.51M | -$244.58M | -$146.35M | -$56.09M | -$34.63M | -$16.02M | -$6.54M |
| EBITDA Margin | -70.4% | -83.7% | -118.9% | -176.3% | -116.8% | -51.6% | -375.8% | -344.8% | -11964.5% | -183897.0% | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Assets | |||||||||||||||
| Current Assets | |||||||||||||||
| Cash and Cash Equivalents | $434M | $173.73M | $213.58M | $132.94M | $307.58M | $713.53M | $433.58M | $113.43M | $100.49M | $161.12M | $93.57M | $24.32M | $7.43M | $86.19M | $10.64M |
| Short-Term Investments | $259M | $436.3M | $363.63M | $614.82M | $432.61M | $488.01M | $321.65M | $346.27M | $134M | $219.03M | $343.43M | $163.16M | $45.95M | $0 | $0 |
| Cash and Short-Term Investments | $693M | $610.02M | $577.21M | $747.76M | $740.2M | $1.2B | $755.23M | $459.71M | $244.47M | $498.11M | $437M | $187.49M | $53.38M | $86.19M | $10.64M |
| Accounts Receivable | $159M | $121.8M | $73.39M | $40.45M | $44.43M | $23.09M | $32.84M | $12.74M | $5.17M | $0 | $0 | $0 | $0 | $0 | $103K |
| Inventory | $52M | $45.01M | $33.97M | $26.77M | $16.23M | $13.05M | $11.55M | $7.07M | $757K | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $47M | $40.29M | $47.62M | $68.93M | $55.74M | $0 | $0 | $0 | $0 | $1.41M | $150K | $5.93M | $0 | $0 | $0 |
| Total Current Assets | $951M | $817.12M | $732.18M | $883.9M | $856.6M | $1.3B | $851.02M | $522.37M | $244.47M | $498.11M | $450.21M | $187.49M | $55.23M | $86.44M | $10.95M |
| Long-Term Assets | |||||||||||||||
| Property, Plant & Equipment Net | $267M | $265.93M | $290.57M | $259.73M | $176.18M | $114.04M | $74.68M | $20.05M | $21.84M | $17.05M | $7.37M | $3.03M | $1.32M | $1.36M | $759K |
| Goodwill | $44M | $44.41M | $44.41M | $44.41M | $44.41M | $44.41M | $44.41M | $44.41M | $44.41M | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $176M | $178.31M | $166.27M | $160.1M | $130.79M | $131.11M | $129M | $129.22M | $141.54M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $59M | $135M | $199.9M | $148.97M | $293.86M | $165.88M | $32.93M | $1.82M | $9.97M | $117.96M | $99.26M | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.82M | $25.11M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $35M | $62.68M | $57.69M | $48.34M | $20.56M | $8.81M | $3.47M | $3.51M | $3.41M | -$92.5M | $2.73M | $7.45M | $3.1M | $509K | $417K |
| Total Long-Term Assets | $581M | $686.33M | $758.83M | $661.54M | $665.79M | $464.25M | $284.48M | $197.19M | $246.28M | $42.52M | $109.36M | $10.48M | $4.42M | $1.87M | $1.18M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.53B | $1.5B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $719.56M | $490.75M | $540.63M | $559.57M | $197.97M | $59.65M | $88.32M | $12.13M |
| Liabilities | |||||||||||||||
| Current Liabilities | |||||||||||||||
| Accounts Payable | $31M | $38.76M | $42.11M | $43.27M | $17.14M | $12.92M | $12.87M | $12.28M | $8.89M | $5.36M | $2.94M | $4.86M | $1.44M | $1.2M | $342K |
| Short-Term Debt | $81M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $1.48M | $7.61M | $59.22M | $0 | $0 | $5.99M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $183M | $87.47M | $142.79M | $0 | $0 | $0 | $0 | $0 | $0 | $37.67M | $15.55M | $85K | $78K | $75K | $0 |
| Total Current Liabilities | $384M | $344.15M | $280.44M | $261.21M | $181.37M | $189.61M | $103.3M | $74.72M | $71.01M | $60.26M | $27.92M | $12.52M | $5.92M | $3.19M | $999K |
| Long-Term Liabilities | |||||||||||||||
| Long-Term Debt | $1.17B | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $1.47M | $7.35M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $30M | $30.06M | $30.06M | $31.67M | $33.31M | $33.31M | $33.31M | $31.17M | $31.17M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | -$4M | $836.91M | $874.53M | $880.26M | $352.79M | $335.67M | $315.37M | $4.76M | $5.12M | $6.39M | $561K | $505K | $3.62M | $788K | $487K |
| Total Long-Term Liabilities | $1.22B | $897.01M | $935.16M | $931.74M | $418.47M | $415.57M | $378.43M | $35.92M | $36.28M | $6.39M | $561K | $505K | $3.62M | $788K | $487K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.6B | $1.24B | $1.22B | $1.19B | $599.84M | $605.18M | $481.73M | $110.65M | $107.3M | $66.65M | $28.48M | $13.02M | $9.54M | $3.98M | $1.49M |
| Stockholders' Equity | |||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $95K | $0 | $0 | $124.93M | $111.39M | $18.6M |
| Common Stock | $0 | $92K | $82K | $70K | $69K | $67K | $58K | $51K | $44K | $41K | $39K | $32K | $4K | $3K | $3K |
| Retained Earnings | -$4.53B | -$3.96B | -$3.39B | -$2.78B | -$2.07B | -$1.62B | -$1.43B | -$1.03B | -$832.67M | -$530.53M | -$284.66M | -$139.04M | -$74.84M | -$27.06M | -$8.15M |
| Comprehensive Income & Other | $1M | -$643K | $647K | -$6.57M | -$1.4M | $689K | -$147K | -$633K | -$5.68M | $905K | -$868K | -$174K | $11K | -$353K | -$40K |
| Other Stockholders' Equity | $4.45B | $4.21B | $3.66B | $3.13B | $3B | $2.77B | $2.09B | $1.64B | $1.22B | $1B | $815.71M | $323.95M | $124.94M | $111.39M | $18.8M |
| Total Equity | -$80M | $255.3M | $275.41M | $352.49M | $922.56M | $1.15B | $653.76M | $608.91M | $383.45M | $473.97M | $531.09M | $184.94M | $50.11M | $84.34M | $10.64M |
| Minority Interest | $7M | $7M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $1.52B | $1.5B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $719.56M | $490.75M | $540.63M | $559.57M | $197.97M | $59.65M | $88.32M | $12.13M |
| Supplementary Data | |||||||||||||||
| Total Debt | $1.28B | $40.34M | $43.17M | $31.59M | $41.97M | $48.23M | $36.99M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Debt | $842M | -$133.39M | -$170.41M | -$101.35M | -$265.61M | -$665.3M | -$396.59M | -$113.43M | -$100.49M | -$161.12M | -$93.57M | -$24.32M | -$7.43M | -$86.19M | -$10.64M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||||
| Net Income | -$575M | -$569.18M | -$606.64M | -$707.42M | -$454.02M | -$186.57M | -$402.73M | -$197.61M | -$302.14M | -$245.87M | -$145.62M | -$59.8M | -$35.07M | -$16.33M | -$6.85M |
| Depreciation & Amortization | $35M | $35.54M | $26.01M | $18.22M | $13.24M | $12.26M | $8.54M | $19.54M | $5.83M | $3.42M | $1.38M | $684K | $444K | $313K | $34K |
| Deferred Income Tax | $0 | $0 | -$1.62M | $0 | $48.67M | -$169.78M | -$18.94M | -$167.65M | -$16.25M | $6.16M | $0 | $0 | $0 | $0 | $13K |
| Stock-Based Compensation | $153M | $158.03M | $135.21M | $130.38M | $104.95M | $85.73M | $82M | $80.11M | $68.01M | $48.31M | $24.88M | $5.39M | $657K | $891K | $254K |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | -$31M | -$33.6M | -$22.78M | -$12.07M | -$5.43M | $9.84M | -$20.1M | -$7.58M | -$5.17M | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | -$6M | -$11.21M | -$6.93M | -$9.7M | -$3.12M | -$1.35M | -$4.45M | -$5.28M | -$757K | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $24M | $46.99M | $2.38M | $79.84M | $2.81M | $29.6M | $20.65M | $3.37M | $3.46M | $2.5M | -$1.98M | $3.18M | $237K | $858K | $252K |
| Other Working Capital | -$10M | $11.73M | $12.23M | $2.16M | -$57.49M | $66.57M | -$12.04M | -$15.3M | -$23.69M | $23.8M | $9.72M | -$1.01M | -$1.78M | $1.47M | $201K |
| Total Working Capital Change | -$23M | $13.92M | -$15.1M | $60.23M | -$63.24M | $104.66M | -$15.94M | -$24.79M | -$20.23M | $26.3M | $7.74M | $2.17M | -$1.54M | $2.32M | $453K |
| Other Non-Cash Items | -$56M | -$52.5M | -$12.67M | $118.12M | $11.71M | $21.46M | $1.69M | -$156K | $10.93M | $700K | $5.64M | $6.92M | $4.31M | $302K | $270K |
| Net Cash from Operating | -$466M | -$414.19M | -$474.81M | -$380.46M | -$338.69M | -$132.22M | -$345.38M | -$290.57M | -$253.84M | -$160.97M | -$105.98M | -$44.63M | -$31.2M | -$12.5M | -$5.83M |
| Investing Activities | |||||||||||||||
| Capital Expenditures | -$6M | -$7.49M | -$44.27M | -$116.12M | -$73.09M | -$43.91M | -$24.83M | -$4.08M | -$2.79M | -$10.19M | -$4.96M | -$2.15M | -$407K | -$1.09M | -$548K |
| Acquisitions | $0 | $0 | $0 | -$75.03M | $0 | $0 | -$11.79M | $0 | -$142.8M | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$186M | -$408.61M | -$526.38M | -$614.74M | -$1.01B | -$850.3M | -$707.16M | -$509.8M | -$230.49M | -$442.49M | -$624.23M | -$208.97M | -$63.95M | $0 | $0 |
| Sales of Investments | $444M | $413.27M | $746.2M | $545.08M | $890.85M | $720.64M | $718.96M | $310.22M | $431.57M | $543.79M | $338.37M | $87.97M | $16.6M | $0 | $0 |
| Other Investing Activities | -$16M | -$14.94M | -$7.55M | -$30.84M | -$942K | -$5.55M | $11.79M | $170.32M | $934K | -$1.2M | -$1.54M | -$293K | $25K | -$100K | -$376K |
| Net Cash from Investing | $236M | -$17.77M | $168M | -$291.65M | -$195.37M | -$179.12M | -$13.04M | -$33.33M | $56.42M | $89.92M | -$292.35M | -$123.44M | -$47.73M | -$1.19M | -$924K |
| Financing Activities | |||||||||||||||
| Debt Repaid | -$392M | - | - | - | - | - | - | - | $4.94M | - | - | - | - | -$100K | -$2.45M |
| Common Stock Issuance | $86M | $380.98M | $379.75M | $0 | $78.94M | $511.21M | $355.24M | $309.02M | $131.96M | $79.49M | $467.57M | $189.32M | $171K | $131K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $18.26M | $8.39M | $501.21M | $39.61M | $89.06M | $324.06M | $27.83M | $9.25M | $59.19M | $6.44M | $736K | $0 | $0 | $0 |
| Net Cash from Financing | $478M | $399.24M | $388.14M | $501.21M | $118.55M | $600.27M | $679.31M | $336.85M | $136.27M | $138.68M | $467.57M | $184.97M | $171K | $89.24M | $17.33M |
| Forex Effect | $5.46M | -$2.52M | $462K | -$1.07M | -$1.19M | $1.12M | -$165K | -$472K | $528K | -$65K | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $253.47M | -$35.24M | $81.8M | -$171.98M | -$416.71M | $290.05M | $320.72M | $12.48M | -$60.63M | $67.55M | $69.25M | $16.9M | -$78.76M | $75.55M | $10.58M |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | -$466M | -$414.19M | -$474.81M | -$380.46M | -$338.69M | -$132.22M | -$345.38M | -$290.57M | -$253.84M | -$160.97M | -$105.98M | -$44.63M | -$31.2M | -$12.5M | -$5.83M |
| Capital Expenditure | -$6M | -$7.49M | -$46.77M | -$146.12M | -$73.09M | -$43.91M | -$24.83M | -$4.08M | -$2.79M | -$10.19M | -$4.96M | -$2.15M | -$407K | -$1.09M | -$548K |
| Free Cash Flow | -$472M | -$421.68M | -$521.57M | -$526.59M | -$411.79M | -$176.13M | -$370.21M | -$294.64M | -$256.64M | -$171.16M | -$110.93M | -$46.78M | -$31.61M | -$13.6M | -$6.37M |
| Cash at Beginning | $184.16M | $219.4M | $137.6M | $309.58M | $726.29M | $436.24M | $115.53M | $103.04M | $161.12M | $93.57M | $24.32M | $7.43M | $86.19M | $10.64M | $65K |
| Cash at End | $436M | $184.16M | $219.4M | $137.6M | $309.58M | $726.29M | $436.24M | $115.53M | $100.49M | $161.12M | $93.57M | $24.32M | $7.43M | $86.19M | $10.64M |